The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in many inflammatory reactions and disorders, and it has become evident that it also affects glucose homeostasis. The protein is produced by pancreatic beta cells and can promote the release of insulin. It also modulates glucose uptake, glycolysis and insulin resistance in insulin target cells such as the adipocyte, myocyte and cardiomyocyte. Possessing both immunological and endocrinological properties, MIF has been associated with the development of type 1 and type 2 diabetes, and it may be important in the setting of islet transplantation. The present review summarises our current knowledge, based on clinical and research data, on the impact of MIF on both physiological and pathological aspects of glucose metabolism.
Toso
C
C
University of Alberta, Edmonton, AB, Canada. christian.toso@hcuge.ch
Emamaullee
J A
JA
Merani
S
S
Shapiro
A M J
AM
D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000378:metabolism / Q000503:physiopathology; D005947:Glucose / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008263:Macrophage Migration-Inhibitory Factors / Q000502:physiology*
D001786:Blood Glucose; D008263:Macrophage Migration-Inhibitory Factors; D005947:Glucose